Journal
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
Volume 14, Issue 5, Pages e243-e251Publisher
WILEY
DOI: 10.1111/ajco.12871
Keywords
basophil; colorectal cancer; eosinophil
Categories
Funding
- National Natural Science Foundation of China [81672436]
- Scientific and Technological Programme of Guangdong [2014A020212333]
- Wu Jie-Ping Medical Foundation [320.2710.1835]
Ask authors/readers for more resources
AimThe effects of circulating eosinophils and basophils on cancer survival are unclear. Here, we aimed to explore the impacts of eosinophils and basophils on prognosis of stage I-III colorectal cancer (CRC) patients. MethodsFrom February 2003 to March 2013, 569 stage I-III CRC patients were enrolled in this retrospective study. The associations between pretreatment circulating eosinophils, basophils and CRC overall survival (OS), disease-free survival (DFS) were investigated. Moreover, the prognostic value of combined eosinophils/basophils and neutrophil to lymphocyte ratio (NLR)/platelet to lymphocyte ratio (PLR) was investigated. ResultsKaplan-Meier methods showed the associations of eosinophils<0.095 x 10(9)/L and shorter OS (P<0.0001), eosinophils<0.055 x 10(9)/L and shorter DFS (P<0.0001), basophils<0.015 x 10(9)/L and shorter OS (P=0.001), basophils<0.015 x 10(9)/L and shorter DFS (P=0.005). Cox regression model showed that eosinophils<0.095 x 10(9)/L (hazard ratio [HR], 1.723; 95% confidence intervals [CI]=1.177-2.523) and basophils<0.015 x 10(9)/L (HR, 1.714; 95% CI=1.152-2.548) were independent prognostic factors for OS, and eosinophils<0.055 x 10(9)/L (HR, 2.309; 95% CI=1.587-3.361) and basophils<0.015 x 10(9)/L (HR, 1.397; 95% CI=1.003-1.945) were independent prognostic factors for DFS, respectively. The combined eosinophil-PLR (HR, 2.611; 95% CI=1.328-5.130) and basophil-PLR (HR, 2.520; 95% CI=1.240-5.123) were the independent prognostic factors for OS. The combined eosinophil-NLR (HR, 2.770; 95% CI=1.528-5.019) and eosinophil-PLR (HR, 4.788; 95% CI=2.458-9.329) were the independent prognostic factors for DFS. ConclusionPretreatment circulating eosinophils<0.095 x 10(9)/L/0.055 x 10(9)/L and circulating basophils<0.015 x 10(9)/L have significant impacts on prognosis of stage I-III CRC patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available